Written by Taylor Woosley, Staff Writer. Results of the MAP longitudinal study show that higher brain MK4 concentrations in all four brain regions resulted in a 17% to 20% lower chance of dementia or mild cognitive impairment occurrence (ORs 0.80 to 0.83, all P-values < .014).
Written by Taylor Woosley, Staff Writer. 2-month supplementation of both 400 mg/day and 800 mg/day of ALA significantly reduced pain management amongst subjects, with both groups experiencing changes in pain scores, decreasing from moderate to mild pain.
Written by Taylor Woosley, Staff Writer. Analyses of observational studies show that increasing ALA intake is associated with a 10% lower risk of total CVD, while a prospective cohort study reported that higher ALA consumption was associated with slower decline in global cognitive functioning.
Written by Taylor Woosley, Staff Writer. Findings of the 28-day study show that treatment consisting of non-surgical periodontal treatment with the use of complex phytoadaptogens (70% alcoholic extract of G. glabra and 40% alcoholic extracts of R. rosea and A. senticosus in a 2:1:1 ratio) effectively relieves inflammation related to chronic periodontitis.
Written by Taylor Woosley, Staff Writer. Results of the study show that deficient and insufficient levels of serum 25-OH-D are associated with higher depression scores. The odds of a higher depression score were significantly higher in participants with insufficient 25-(OH)-D than in participants with 25-OH-D sufficiency (OR = 6.40, p < 0.001).
Written by Taylor Woosley, Staff Writer. 12-week supplementation with blueberry powder (equivalent to 0.5 c of blueberries) resulted in significant improvement in lexical access and a reduction of recall intrusion errors, with a significant decline in fasting insulin noted at the 12-week mark.
Written by Jessica Patella, ND. Study results show supplementing with 500mg/day of citicoline helped to improve memory in healthy older adults.
Written by Marlene Hollick, Ed.D., R.D. Based on a t-test of matched samples in this double-blind, placebo-controlled, randomized study on the effects of RLX2™ (alpha-s1-casein tryptic hydrolysate & L-Theanine) oral supplement on sleep quality, results indicated that subjects who received this treatment demonstrated significant improvements in reported sleep duration and quality.
Written by Taylor Woosley, Staff Writer. Subjects consuming ≥2 servings/week of avocadoes had a 16% lower risk of developing cardiovascular disease and a 21% lower risk of coronary heart disease incidence.
Written by Taylor Woosley, Staff Writer. Participants in the highest mushroom intake group had reduced odds of cognitive decline, scoring higher on the CERAD-WL test (assesses new verbal learning) and the Digit Symbol Substitution Test (evaluates attention and processing speed).
